Corporate

Meet our faculty: Naomi Ginsberg

May 21, 2020
Naomi Ginsberg credits her love of learning as the driving force behind her unusual academic journey.

Semisynthetic artemisinin anti-malarials reach African children

August 15, 2014

Jay Keasling with children in a village outside Nairobi, Kenya. (Photo by Gabrielle Tenenbaumn)1.7 million treatments of semisynthetic artemisinin have shipped to Africa, where they will treat malaria sufferers in Burkina Faso, Burundi, Democratic Republic of the Congo, Liberia, Niger and Nigeria over the next few months. This shipment is the culmination of a 13-year project in the lab of CBE professor Jay Keasling. Enough semisynthetic artemisinin has been produced for 70 million treatments, and the capacity exists to produce 100-150 million treatments annually.

CoC launches research hub with BASF, UCLA and Stanford

April 3, 2014
The College of Chemistry has launched a new collaborative research center, the California Research Alliance by BASF (CARA), a multidisciplinary effort focused on innovation and technology transfer. Along with Berkeley and the chemical company BASF, CARA academic partners include UCLA and Stanford University.

BASF donates $7 million toward construction of new UC Berkeley science and engineering hub

July 13, 2018


Boreskov Institute of CatalysisMartin Brudermüller, Chairman of the Board and CTO, BASF SE has announced a donation of $7 million to UC Berkeley at the California Research Alliance 2018 Summer Symposium.

How DayGlo went from utility pigment to design world-darling

August 30, 2018


Switzer brothers demonstrate DayGlo colorsToday DayGlo pigments color everything from traffic cones to tennis shoes, but back in the 1930s it was barely used at all. Though Joe and Bob Switzer can lay claim to commercializing fluorescent pigments, they were far from the first people to discover the phenomenon. By the time Joe and Bob created their homemade paint, scientists had already spent years in the laboratory exploring the chemical makeup of glowing substances.

Jnana Therapeutics announces appointment of alum Joanne Kotz, Ph.D. as Chief Executive Officer

November 6, 2018

Joanne Kotze, PhD, Jnana TherapeuticsJnana Therapeutics today announced that UC Berkeley Chemistry alum Joanne Kotz, Ph.D., a company co-founder, has been named Chief Executive Officer. Dr. Kotz has served as Jnana's president since December 2017. For more information...